Phase III trial of EndoTAG-1 in patients with pancreatic cancer.
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2011
At a glance
- Drugs Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Sponsors MediGene AG
- 11 Nov 2011 Trial not yet initiated.
- 17 Dec 2009 New trial record
- 15 Dec 2009 This trial is anticipated to begin in the first half of 2011 according to a MediGene AG media release.